GLP-1: Glucagon-Like Peptide-1 An incretin hormone that stimulates insulin secretion, reduces glucagon release, slows gastric emptying, and Suppresses appetite, aiding weight loss
The most common retatrutide side effects are nausea, diarrhoea, constipation, vomiting, bloating, burping and indigestion
Your body is experiencing the metabolic shift for the first time, caloric intake has dropped, blood sugar regulation is adjusting, and electrolytes may already be depleting
AOD 9604 targets fat metabolism directly
Results are based on self-reported data from ~10,000 DosePop patients on personalized treatment plans, including compounded GLP-1based therapies and clinician consultations
Most standard supplements are fine during fasting windows, including vitamins, minerals, creatine, and electrolytes